product summary
request information :
company name :
LifeSpan Biosciences
product type :
ELISA/assay
product name :
Dog Progesterone ELISA Kit (Competitive EIA) - LS-F10047
catalog :
LS-F10047
quantity :
50 - 100 Microliters
more info or order :
LifeSpan Biosciences product webpage
product information
?ElisaKitId :
10047
ElisaKitType :
Competitive EIA
CatalogNumber :
LS-F10047
TargetSpecies :
Dog
Product Name :
Dog Progesterone ELISA Kit (Competitive EIA) - LS-F10047
Specificity :
This assay has high sensitivity and excellent specificity for detection of canine PROG. No significant cross-reactivity or interference between canine PROG and analogs was observed. Note: Limited by current skills and knowledge, it is impossible for us to complete the cross-reactivity detection between canine PROG and all the analogs, therefore, cross reaction may still exist.
SampleType :
Plasma, Serum, Tissue Homogenates
SampleSize :
50 - 100 Microliters
MeasurementType :
Quantitative
FormatType :
96-Well Microplate
DetectionRange :
0.125 - 50 Nanograms per millilter
RecommendedStorage :
2°C to 8°C
Precision :
Intra-assay: CV%<15% Inter-assay: CV%<15%
Gene :
Progesterone
Reactivity :
Dog
ProductID :
12463
ProductNumber :
LS-F10047-1
Size :
1 plate
more info or order :
LifeSpan Biosciences product webpage
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.